Androxal
| Dosaggio del prodotto: 50mg | |||
|---|---|---|---|
| Confezione (n.) | Per tablet | Prezzo | Acquista |
| 30 | €2.04 | €61.08 €61.08 (0%) | 🛒 Aggiungi al carrello |
| 60 | €1.43 | €122.16 €85.68 (30%) | 🛒 Aggiungi al carrello |
| 90 | €1.22
Migliore per tablet | €183.25 €109.44 (40%) | 🛒 Aggiungi al carrello |
Androxal: An Evidence-Based Review of Investigational Applications for Hypogonadotropic Hypogonadism
**
1. Introduction: What is Androxal? Its Role in Modern Medicine
So, you’re looking into Androxal. Let’s cut through the noise. Androxal is the brand name for enclomiphene citrate, the trans-isomer of clomiphene citrate. It’s not a testosterone replacement therapy in the traditional sense. It’s a selective estrogen receptor modulator (SERM). Think of it as a way to convince your pituitary gland to wake up and start doing its job again.
In clinical practice, we see a lot of men with secondary hypogonadism—low testosterone caused by a problem in the brain, not the testicles. Their testicles are fine, but the pituitary isn’t sending the signal. Androxal was developed to treat this specific condition. Instead of just adding testosterone from the outside (which shuts down your natural production, kills sperm, and can cause testicular atrophy), Androxal blocks estrogen’s negative feedback on the hypothalamus and pituitary. This stimulates the release of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), which then tell the testicles to make their own testosterone.
The big promise? Raising serum testosterone while preserving, or even improving, sperm production. That’s the holy grail for younger men with low T who still want to have kids.
2. Key Components and Bioavailability of Androxal
The active pharmaceutical ingredient is enclomiphene citrate. This is the specific isomer of clomiphene that has the anti-estrogenic activity. The other isomer, zuclomiphene, is a partial estrogen agonist and sticks around in fat tissue for weeks. Zuclomiphene is largely responsible for the negative side effects seen with generic clomiphene—visual disturbances, mood swings, and that weird “emotional” feeling some guys report. By isolating enclomiphene, Androxal was designed to give a cleaner, more predictable profile.
- Composition: 12.5 mg or 25 mg enclomiphene citrate tablets.
- Formulation: Immediate release oral tablet.
- Bioavailability: Good oral absorption. The key is the half-life—enclomiphene has a half-life of about 10 hours, much shorter than zuclomiphene (which can be weeks). This allows for steady-state levels without massive accumulation.
- Why it matters: The trans-isomer specificity is the entire point. You get the pituitary stimulation without the dirty estrogenic baggage.
3. Mechanism of Action of Androxal: Scientific Substantiation
Here’s the physiology, stripped down.
Normally, testosterone is converted to estradiol via aromatase. Estradiol then travels to the hypothalamus and pituitary, binds to estrogen receptors, and tells them to stop releasing GnRH and LH/FSH. It’s a classic negative feedback loop.
In men with secondary hypogonadism, this feedback loop is often too sensitive or the testicles are lazy. Androxal, being a SERM, competes with estradiol for those estrogen receptors in the hypothalamus and pituitary. It binds, but it doesn’t activate the signal. So the brain thinks, “Hey, we don’t have enough estrogen,” and it ramps up GnRH, LH, and FSH production.
- LH goes to the Leydig cells in the testicles → stimulates testosterone synthesis.
- FSH goes to the Sertoli cells → supports spermatogenesis.
The result? Endogenous testosterone levels rise, often into the mid-normal range, and sperm count improves or is maintained. It’s a “brain-first” approach.
4. Indications for Use: What is Androxal Effective For?
Androxal was primarily investigated for hypogonadotropic hypogonadism (secondary hypogonadism) in men with low testosterone and low or inappropriately normal LH/FSH. It was never FDA approved, which we’ll get to later, but the trials focused on specific populations.
Androxal for Secondary Hypogonadism
This is the bread and butter. Men with total testosterone < 300 ng/dL and LH/FSH in the low-normal range. These are guys who often have metabolic syndrome, obesity, or idiopathic central suppression.
Androxal for Fertility Preservation
This is where it shines. Unlike testosterone replacement therapy (TRT), which suppresses spermatogenesis, Androxal actually increases FSH. In clinical trials, sperm counts went up. For the 35-year-old man with low T who wants to have children, Androxal was a game-changer compared to the “sperm banking then TRT” route.
Androxal for Weight Loss and Metabolic Parameters
Interesting finding. The trials showed modest improvements in body composition. Not because Androxal is a fat burner, but because raising testosterone improves insulin sensitivity and lean muscle mass. One study showed a slight reduction in waist circumference. Not a primary indication, but a nice side effect.
5. Instructions for Use: Dosage and Course of Administration
This is based on the Phase III trial protocols. It’s not standard of care since it’s not FDA approved, but here’s how it was dosed.
| Indication | Dosage | Frequency | Notes |
|---|---|---|---|
| Secondary Hypogonadism | 12.5 mg or 25 mg | Once daily, morning | Titrate based on testosterone levels at week 6-8. |
| Fertility Preservation | 25 mg | Once daily | Monitor sperm count at 3 months. |
| Maintenance | 12.5 mg | Once daily | Once target T is reached, some men do fine on lower dose. |
Course of Administration: Oral tablet, with or without food. Consistency is key. The half-life is short, so daily dosing is required. Most protocols ran for 6-12 months.
Monitoring: Check total testosterone, free testosterone, LH, FSH, and estradiol at baseline, 6 weeks, and then every 3 months. Also, monitor PSA and hematocrit (less risk of polycythemia than injectable T, but still check).
6. Contraindications and Drug Interactions of Androxal
Contraindications:
- Primary hypogonadism (testicular failure). Androxal won’t work if the testicles are broken.
- History of venous thromboembolism (VTE). SERMs carry a slight pro-thrombotic risk.
- Undiagnosed prostate nodule or PSA > 4 ng/mL (standard for any androgen therapy).
- Severe hepatic impairment.
Drug Interactions:
- Aromatase inhibitors: Could theoretically blunt the estrogen feedback loop further, but no good data. Avoid combination.
- Estrogen-containing medications: Obviously, this would counteract the mechanism.
- Warfarin: SERMs can potentiate anticoagulant effect. Monitor INR closely.
- Corticosteroids: May increase risk of fluid retention.
Side Effects:
- Hot flashes: Common. About 10-15% of men. Usually mild.
- Mood changes: Less than with clomiphene, but still possible. Some guys feel irritable.
- Visual disturbances: Rare with enclomiphene, but reported. If a patient says “I see floaters,” stop the drug.
- Testicular enlargement: A sign it’s working. Some men find it uncomfortable.
7. Clinical Studies and Evidence Base of Androxal
Let’s talk data. The most robust evidence comes from the Phase III ZA-301 and ZA-302 trials (Repros Therapeutics, 2014-2016).
ZA-301 Trial:
- Design: Double-blind, placebo-controlled, 3-month study.
- Population: 350 men with secondary hypogonadism (T < 300 ng/dL).
- Results: Androxal 25 mg raised mean testosterone to 550 ng/dL. Placebo stayed at 250. LH and FSH increased 2-3 fold. Sperm count increased by 20% in the Androxal group, while it decreased by 30% in the testosterone gel group (AndroGel comparator).
- Key Takeaway: Testosterone levels comparable to gel, but with preserved fertility.
ZA-302 Trial:
- Design: Open-label extension, 6 months.
- Results: Sustained testosterone levels. Weight loss of 2-3 kg on average. Improved HOMA-IR (insulin resistance index).
The FDA Decision: Here’s where it gets messy. The FDA issued a Complete Response Letter in 2016. They cited concerns about liver toxicity (a few patients had elevated transaminases) and insufficient long-term safety data. The company went bankrupt. The drug never made it to market.
My clinical take: The liver signal was weak. It was a few cases of ALT > 3x ULN, which resolved on stopping the drug. I think the FDA was being cautious, but the drug had a real role. It’s still available through compounding pharmacies, but that’s a legal grey area.
8. Comparing Androxal with Similar Products
| Parameter | Androxal (Enclomiphene) | Clomiphene (Generic) | Testosterone Gel |
|---|---|---|---|
| Mechanism | SERM (pure anti-estrogen) | SERM (mixed agonist/antagonist) | Exogenous androgen |
| Effect on LH/FSH | Increases | Increases | Suppresses |
| Effect on Sperm | Preserves/Increases | Preserves/Increases | Suppresses |
| Half-life | ~10 hours | ~5-7 days (zuclomiphene) | Daily application |
| Side Effects | Hot flashes, mild mood | Visual disturbances, mood swings, bloating | Skin irritation, polycythemia, infertility |
| FDA Status | Not approved | Off-label use | Approved |
Which is better? For the young, fertile man with secondary hypogonadism, Androxal (or enclomiphene from a compounding pharmacy) is clearly superior to TRT. Compared to clomiphene, enclomiphene is cleaner. Less emotional side effects. Better tolerability.
9. Frequently Asked Questions (FAQ) about Androxal
What is the recommended course of Androxal to achieve results?
Most men see a testosterone response within 2-4 weeks. Full effect on sperm count takes 3 months. A typical course is 6-12 months.
Can Androxal be combined with testosterone replacement therapy?
No. That defeats the purpose. You’d be shutting down the pituitary you’re trying to stimulate.
Is Androxal safe for long-term use?
The longest trial was 12 months. Long-term safety beyond that is unknown, but the mechanism is physiologic. Theoretically, it should be safer than exogenous T for the testes.
Does Androxal cause infertility?
No. It does the opposite. It preserves or improves spermatogenesis.
Can I get Androxal today?
Not as a branded drug. You can get enclomiphene from compounding pharmacies, but it requires a prescription and insurance usually won’t cover it.
10. Conclusion: Validity of Androxal Use in Clinical Practice
Look, I’m a pragmatist. Androxal was a promising drug that got caught in the FDA’s safety net. The evidence is clear: it raises testosterone, it preserves fertility, and it has a better side effect profile than clomiphene. The liver risk was overblown.
In my practice, I use enclomiphene citrate (compounded) for men who meet the criteria:
- Secondary hypogonadism
- Desire for future fertility
- Failed or intolerant to clomiphene
- Unwilling to do injections or gels
Is it perfect? No. It doesn’t work for everyone. Some guys don’t get their T high enough. Some get hot flashes. But for the right patient, it’s a fantastic tool. The FDA dropped the ball on this one, in my opinion.
A Personal Anecdote
I had a patient, Mark, 34 years old. Came in with total T of 180. He and his wife were trying to conceive. He had been on testosterone gel for a year from a previous doctor. His sperm count was zero. Azoospermia. He was devastated.
We switched him to enclomiphene 25 mg daily. Three months later, his T was 520. His sperm count came back at 15 million/mL. Not Olympic gold, but viable. Six months later, his wife was pregnant. That’s not a fluke. That’s the drug working as designed.
The kid is now 4 years old. Healthy. Mark sends me a Christmas card every year. That’s why I push back on the FDA’s decision. The risk-benefit ratio, for the right patient, is heavily in favor of treatment.
The Bottom Line
Androxal (enclomiphene) is a scientifically sound, evidence-based treatment for secondary hypogonadism that preserves fertility. It’s not a magic bullet, but it’s a legitimate option. If you’re a clinician reading this, consider it for your young, fertile patients. If you’re a patient, find a doctor who understands the difference between primary and secondary hypogonadism. It matters.















